BioSpace News Archive

Analysis of 45,000 hours of data finds that significant care disparities can result in pressure injuries when technology is not used to coordinate care

Appointment of Shay Soker, Professor at the Wake Forest Institute for Regenerative Medicine (WFIRM), to its Scientific Advisory Board.

Campaign Goes Live in June as part of Company’s “Summer of Impact”

According to a new study, advocates for national pharmacare have misdiagnosed the nature of gaps in prescription drug plan coverage in Canada and therefore have proposed the wrong solution.

Cherif Habib, Co-Founder and CEO of virtual healthcare platform Dialogue Technologies (“Dialogue”), is pleased to announce the appointment of Dr. Julien Martel as Chief Medical Officer.

Amgen Canada announced that Health Canada has now indicated Repatha as an adjunct to diet and standard of care therapy (including moderate- to high-intensity statin therapy alone or in combination with other lipid-lowering therapy), to reduce the risk of myocardial infarction, stroke, and coronary revascularization in adult patients with atherosclerotic cardiovascular disease.

ReShape Lifesciences Inc. announces that the United States Patent and Trademark Office (“USPTO”) has issued an Issue Notification for U.S. Patent Number 10010441 entitled “Gastric Restriction Device for Treating Obesity,”

Earnings Call Scheduled for 8:00 a.m. ET on June 27, 2018

China Biologic Products Holdings, Inc. announced that its board of directors (the “Board”) has received an unsolicited, preliminary non-binding proposal letter from CCRE Holdings Limited

New guide for patients addresses growing interest in probiotics